AVITA Medical, Inc.

NASDAQ:RCEL

Medical - Devices

Healthcare
$16.83 -0.25%

+$0.00 today

Market cap
$418.11M
Beta
1.86
P/E (TTM)
-0.0
EPS (TTM)
-$148.45
52W Low $3.22High $7.12

Volume 0.72M

Average 0.24M

RCEL Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

AVITA Medical, Inc.NASDAQ: RCEL

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 305.41K shares fell 98.8% year over year, behind the -17.9% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 99.0% from the prior quarter. Over 3 fiscal years it compounded at +3.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -98.8% toward the trailing-twelve-month pace of -17.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
305.41K-99.0% QoQ
Last fiscal yearDec 2025
27.86M+7.6% YoY
LTMMar 2026
21.36M-17.9% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-98.8%——
1 year+7.6%——
3-year CAGR+3.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
27.86M USD
Year-over-year change
+7.6%
4-year CAGR
+3.4%

Weighted Avg Shares vs competitors

How RCEL compares with its peers on the latest reported figures

  • RCEL's LTM Mar 2026 weighted avg shares of 21.36M shares is the 8th highest of the 9 companies compared; the peer median is 79.6M shares.
  • Its year-over-year change of -17.9% is the lowest of 9, against a peer median of +15.8%.
  • Over three fiscal years its annual growth of +3.7% compares with a peer median of +12.1%.
RCEL Competitors Peer median
Weighted Avg Shares for RCEL and competitors
Company Period LTM YoY 3-year CAGR
XTNTXtant Medical Holdings, Inc.LTM Mar 2026139.57M +1.9%+14.0%
LUCDLucid Diagnostics Inc.LTM Mar 2026102.76M +82.6%+41.3%
HYPRHyperfine, Inc.LTM Mar 202687.25M +18.9%+10.2%
STTKShattuck Labs, Inc.LTM Mar 202684.8M +66.7%+18.0%
OVIDOvid Therapeutics Inc.LTM Mar 202674.41M +4.8%+1.5%
VANIVivani Medical, Inc.LTM Mar 202665.65M +15.7%+17.7%
APYXApyx Medical CorporationLTM Mar 202641.45M +15.9%+6.9%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
FONRFONAR CorporationLTM Mar 20266.22M -2.6%-1.2%
Peer median (excluding RCEL) 79.6M+15.8%+12.1%

Competitors are the stored peer set for RCEL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue33.03M34.42M50.14M64.25M71.61M
Cost of Revenue6.1M6.04M7.78M9.09M12.79M
Gross Profit26.92M28.38M42.36M55.16M58.82M
Gross Margin81.5%82.4%84.5%85.8%82.1%
Research & Development15.67M13.86M20.82M20.36M20.84M
Selling, General & Admin37.21M45.24M65.63M91.39M79.91M
Operating Expenses52.04M55.89M85.02M111.75M100.75M
Depreciation & Amortization673K568K632K1.13M2.35M
EBITDA(24.4M)(26.05M)(33.54M)(55.3M)(39.59M)
EBITDA Margin-73.9%-75.7%-66.9%-86.1%-55.3%
Operating Income(25.12M)(27.51M)(42.66M)(56.59M)(41.93M)
Operating Margin-76.1%-79.9%-85.1%-88.1%-58.6%
Interest Income00000
Interest Expense29K16K1.14M5.36M5M
Other Income / Expenses18K876K7.34M(5.2M)(6.64M)
Income Before Tax(25.1M)(26.63M)(35.32M)(61.79M)(48.58M)
Pre-Tax Margin-76.0%-77.4%-70.4%-96.2%-67.8%
Income Tax Expense42K36K66K54K11K
Net Income(25.14M)(26.67M)(35.38M)(61.85M)(48.59M)
Net Margin-76.1%-77.5%-70.6%-96.3%-67.8%
EPS (Basic)(1.03)(1.07)(1.40)(2.39)(1.74)
EPS (Diluted)(1.03)(1.07)(1.40)(2.39)(1.74)
Weighted Avg Shares24.36M25M25.33M25.88M27.86M
Weighted Avg Shares (Diluted)24.36M25M25.33M25.88M27.86M

AVITA Medical, Inc.

NASDAQ:RCEL

Intrinsic Alpha fair value

Locked

Current Price

$16.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.